All In MedTech

FDA Clearance Tracker · P160022-S046

X Series®; Propaq MD®; AED 3™ BLS; Zenix Professional Defibrillators

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 18, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P160022-S046
Device name
X Series®; Propaq MD®; AED 3™ BLS; Zenix Professional Defibrillators
Applicant location
Chelsmford, MA
Received
Jul 3, 2025
Decided
Dec 18, 2025
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P160022

Device type

Device class
Class III
Regulation
21 CFR 870.5310

Every decision under product code MKJ

FDA's approval statement

As written in FDA's record.

approval for updates to the labeling to add post-approval study results.

Source documents

Other decisions for ZOLL Medical Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.